Please login to the form below

Not currently logged in
Email:
Password:

New EMA fees come into effect

Covers all types of procedures, including marketing-authorisation applications and scientific advice

The European Medicines Agency (EMA) has increased its fees for handling procedures like marketing-authorisation applications, inspections and scientific advice.

The fees, which are paid by applicants and marketing-authorisation holders, rose by 3.1 per cent as of yesterday.

The European regulator said all applications received by March 31 would be charged at the previous fee and reduction rates.

For scientific advice and protocol assistance for human medicines the cut-off point will be the date of validation of the request for advice, while for annual fees their anniversary date will define the applicable fee.

The EMA adjusts its fees every year on April 1, in line with the European Union (EU) inflation rate for the previous year, as published in the Official Journal of the European Union.

• More information on the fees payable to the European Medicines Agency

2nd April 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....